Advertisement

Index by Author

April 1999; 48 (4)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Alessi, M C

    • Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes April 1999 48:890-895; doi:10.2337/diabetes.48.4.890

  2. Allen, L I

    • Allelic drop-out in exon 2 of the hepatocyte nuclear factor-1alpha gene hinders the identification of mutations in three families with maturity-onset diabetes of the young. Diabetes April 1999 48:921-923; doi:10.2337/diabetes.48.4.921

  3. Andreelli, F

    • Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes April 1999 48:699-705; doi:10.2337/diabetes.48.4.699

  4. Aubert, J

    • Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes April 1999 48:890-895; doi:10.2337/diabetes.48.4.890

  5. Auboeuf, D

    • Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes April 1999 48:699-705; doi:10.2337/diabetes.48.4.699

  6. Auwerx, J

    • Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes April 1999 48:699-705; doi:10.2337/diabetes.48.4.699

  7. Averill, S A

    • Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes April 1999 48:881-889; doi:10.2337/diabetes.48.4.881

B

  1. Bai, W

    • Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes April 1999 48:855-864; doi:10.2337/diabetes.48.4.855

  2. Barbosa, J

    • Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes April 1999 48:865-869; doi:10.2337/diabetes.48.4.865

  3. Baskin, D G

    • Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes April 1999 48:828-833; doi:10.2337/diabetes.48.4.828

  4. Bautista, O

    • Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes April 1999 48:870-880; doi:10.2337/diabetes.48.4.870

  5. Beattie, G M

    • Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes April 1999 48:745-753; doi:10.2337/diabetes.48.4.745

  6. Bennett, P H

    • Effect of glycemia on mortality in Pima Indians with type 2 diabetes. Diabetes April 1999 48:896-902; doi:10.2337/diabetes.48.4.896

  7. Bergholm, R

    • Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes April 1999 48:821-827; doi:10.2337/diabetes.48.4.821

  8. Berman, N

    • Glucose entrainment of high-frequency plasma insulin oscillations in control and type 2 diabetic subjects. Diabetes April 1999 48:714-721; doi:10.2337/diabetes.48.4.714

  9. Bier, D M

    • Gluconeogenesis in very low birth weight infants receiving total parenteral nutrition. Diabetes April 1999 48:791-800; doi:10.2337/diabetes.48.4.791

  10. Boden, G

    • Effect of insulin on fat metabolism during and after normal pregnancy. Diabetes April 1999 48:834-838; doi:10.2337/diabetes.48.4.834

  11. Breininger, J F

    • Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes April 1999 48:828-833; doi:10.2337/diabetes.48.4.828

  12. Buchanan, T A

    • Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes April 1999 48:848-854; doi:10.2337/diabetes.48.4.848

  13. Bulman, M P

    • Allelic drop-out in exon 2 of the hepatocyte nuclear factor-1alpha gene hinders the identification of mutations in three families with maturity-onset diabetes of the young. Diabetes April 1999 48:921-923; doi:10.2337/diabetes.48.4.921

C

  1. Canani, L H

    • Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes April 1999 48:909-913; doi:10.2337/diabetes.48.4.909

  2. Cerasi, E

    • Interaction between genetic and dietary factors determines beta-cell function in Psammomys obesus, an animal model of type 2 diabetes. Diabetes April 1999 48:731-737; doi:10.2337/diabetes.48.4.731
    • Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes April 1999 48:738-744; doi:10.2337/diabetes.48.4.738

  3. Chait, A

    • Inhibition of LDL oxidation in vitro but not ex vivo by troglitazone. Diabetes April 1999 48:783-790; doi:10.2337/diabetes.48.4.783

  4. Charron, M J

    • Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle. Diabetes April 1999 48:775-782; doi:10.2337/diabetes.48.4.775

  5. Chen, C S

    • Activation of protein kinase B and induction of adipogenesis by insulin in 3T3-L1 preadipocytes: contribution of phosphoinositide-3,4,5-trisphosphate versus phosphoinositide-3,4-bisphosphate. Diabetes April 1999 48:691-698; doi:10.2337/diabetes.48.4.691

  6. Chen, W

    • Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle. Diabetes April 1999 48:775-782; doi:10.2337/diabetes.48.4.775

  7. Chen, X

    • Effect of insulin on fat metabolism during and after normal pregnancy. Diabetes April 1999 48:834-838; doi:10.2337/diabetes.48.4.834

  8. Cirulli, V

    • Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes April 1999 48:745-753; doi:10.2337/diabetes.48.4.745

  9. Clausen, J O

    • Intermediate expansions of a GAA repeat in the frataxin gene are not associated with type 2 diabetes or altered glucose-induced beta-cell function in Danish Caucasians. Diabetes April 1999 48:914-917; doi:10.2337/diabetes.48.4.914

  10. Cleary, P A

    • Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes April 1999 48:870-880; doi:10.2337/diabetes.48.4.870

  11. Cockcroft, J

    • Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes April 1999 48:821-827; doi:10.2337/diabetes.48.4.821

  12. Cram, D S

    • Laminin-1 promotes differentiation of fetal mouse pancreatic beta-cells. Diabetes April 1999 48:722-730; doi:10.2337/diabetes.48.4.722

  13. Crawford, R S

    • Inhibition of LDL oxidation in vitro but not ex vivo by troglitazone. Diabetes April 1999 48:783-790; doi:10.2337/diabetes.48.4.783

D

  1. Dahms, W

    • Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes April 1999 48:870-880; doi:10.2337/diabetes.48.4.870

  2. Dalgaard, L T

    • Intermediate expansions of a GAA repeat in the frataxin gene are not associated with type 2 diabetes or altered glucose-induced beta-cell function in Danish Caucasians. Diabetes April 1999 48:914-917; doi:10.2337/diabetes.48.4.914

  3. Davalli, A M

    • Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats. Diabetes April 1999 48:801-812; doi:10.2337/diabetes.48.4.801

  4. DeAizpurua, H J

    • Laminin-1 promotes differentiation of fetal mouse pancreatic beta-cells. Diabetes April 1999 48:722-730; doi:10.2337/diabetes.48.4.722

  5. Dekker, J M

    • Altered beta-cell characteristics in impaired glucose tolerant carriers of a GAA trinucleotide repeat polymorphism in the frataxin gene. Diabetes April 1999 48:924-926; doi:10.2337/diabetes.48.4.924

  6. Donath, M Y

    • Interaction between genetic and dietary factors determines beta-cell function in Psammomys obesus, an animal model of type 2 diabetes. Diabetes April 1999 48:731-737; doi:10.2337/diabetes.48.4.731
    • Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes April 1999 48:738-744; doi:10.2337/diabetes.48.4.738

  7. Dronsfield, M J

    • Allelic drop-out in exon 2 of the hepatocyte nuclear factor-1alpha gene hinders the identification of mutations in three families with maturity-onset diabetes of the young. Diabetes April 1999 48:921-923; doi:10.2337/diabetes.48.4.921

E

  1. Easom, R A

    • CaM kinase II: a protein kinase with extraordinary talents germane to insulin exocytosis. Diabetes April 1999 48:675-684; doi:10.2337/diabetes.48.4.675

  2. Eiberg, H

    • Intermediate expansions of a GAA repeat in the frataxin gene are not associated with type 2 diabetes or altered glucose-induced beta-cell function in Danish Caucasians. Diabetes April 1999 48:914-917; doi:10.2337/diabetes.48.4.914

  3. Eizirik, D L

    • Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes April 1999 48:706-713; doi:10.2337/diabetes.48.4.706

  4. Ellard, S

    • Allelic drop-out in exon 2 of the hepatocyte nuclear factor-1alpha gene hinders the identification of mutations in three families with maturity-onset diabetes of the young. Diabetes April 1999 48:921-923; doi:10.2337/diabetes.48.4.921

  5. Eriksson, U J

    • Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. Diabetes April 1999 48:813-820; doi:10.2337/diabetes.48.4.813

F

  1. Factor, S M

    • Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle. Diabetes April 1999 48:775-782; doi:10.2337/diabetes.48.4.775

  2. Fernandez, J

    • Glucose-dependent stimulatory effect of glucagon-like peptide 1(7-36) amide on the electrical activity of pancreatic beta-cells recorded in vivo. Diabetes April 1999 48:754-757; doi:10.2337/diabetes.48.4.754

  3. Fernyhough, P

    • Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes April 1999 48:881-889; doi:10.2337/diabetes.48.4.881

  4. Fioretto, P

    • Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes April 1999 48:865-869; doi:10.2337/diabetes.48.4.865

  5. Flatt, P R

    • NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity. Diabetes April 1999 48:758-765; doi:10.2337/diabetes.48.4.758

  6. Flodström, M

    • Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes April 1999 48:706-713; doi:10.2337/diabetes.48.4.706

  7. Fogarty, J

    • Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes April 1999 48:870-880; doi:10.2337/diabetes.48.4.870

  8. Frayling, T M

    • Allelic drop-out in exon 2 of the hepatocyte nuclear factor-1alpha gene hinders the identification of mutations in three families with maturity-onset diabetes of the young. Diabetes April 1999 48:921-923; doi:10.2337/diabetes.48.4.921

  9. Frühbeck, G

    • Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes April 1999 48:903-908; doi:10.2337/diabetes.48.4.903

G

  1. Gagnon, A

    • Activation of protein kinase B and induction of adipogenesis by insulin in 3T3-L1 preadipocytes: contribution of phosphoinositide-3,4,5-trisphosphate versus phosphoinositide-3,4-bisphosphate. Diabetes April 1999 48:691-698; doi:10.2337/diabetes.48.4.691

  2. Gallagher, A

    • Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes April 1999 48:881-889; doi:10.2337/diabetes.48.4.881

  3. Genuth, S

    • Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes April 1999 48:870-880; doi:10.2337/diabetes.48.4.870

  4. Gerchman, F

    • Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes April 1999 48:909-913; doi:10.2337/diabetes.48.4.909

  5. Giacca, A

    • Free fatty acids impair hepatic insulin extraction in vivo. Diabetes April 1999 48:766-774; doi:10.2337/diabetes.48.4.766

  6. Giorgino, F

    • Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats. Diabetes April 1999 48:801-812; doi:10.2337/diabetes.48.4.801

  7. Goodpaster, B H

    • Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes April 1999 48:839-847; doi:10.2337/diabetes.48.4.839

  8. Groop, L C

    • Expression of naturally occurring variants in the muscle glycogen synthase gene. Diabetes April 1999 48:918-920; doi:10.2337/diabetes.48.4.918

  9. Gross, D J

    • Interaction between genetic and dietary factors determines beta-cell function in Psammomys obesus, an animal model of type 2 diabetes. Diabetes April 1999 48:731-737; doi:10.2337/diabetes.48.4.731
    • Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes April 1999 48:738-744; doi:10.2337/diabetes.48.4.738

  10. Gross, J L

    • Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes April 1999 48:909-913; doi:10.2337/diabetes.48.4.909

H

  1. Hansen, T

    • Intermediate expansions of a GAA repeat in the frataxin gene are not associated with type 2 diabetes or altered glucose-induced beta-cell function in Danish Caucasians. Diabetes April 1999 48:914-917; doi:10.2337/diabetes.48.4.914

  2. Harrison, L C

    • Laminin-1 promotes differentiation of fetal mouse pancreatic beta-cells. Diabetes April 1999 48:722-730; doi:10.2337/diabetes.48.4.722

  3. Hattersley, A T

    • Allelic drop-out in exon 2 of the hepatocyte nuclear factor-1alpha gene hinders the identification of mutations in three families with maturity-onset diabetes of the young. Diabetes April 1999 48:921-923; doi:10.2337/diabetes.48.4.921

  4. Hayek, A

    • Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes April 1999 48:745-753; doi:10.2337/diabetes.48.4.745

  5. Haymond, M W

    • Gluconeogenesis in very low birth weight infants receiving total parenteral nutrition. Diabetes April 1999 48:791-800; doi:10.2337/diabetes.48.4.791

  6. Heine, R J

    • Altered beta-cell characteristics in impaired glucose tolerant carriers of a GAA trinucleotide repeat polymorphism in the frataxin gene. Diabetes April 1999 48:924-926; doi:10.2337/diabetes.48.4.924

  7. Henry, R R

    • Inhibition of LDL oxidation in vitro but not ex vivo by troglitazone. Diabetes April 1999 48:783-790; doi:10.2337/diabetes.48.4.783

  8. Hiai, H

    • Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes April 1999 48:927-932; doi:10.2337/diabetes.48.4.927

  9. Hirshman, M F

    • Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats. Diabetes April 1999 48:801-812; doi:10.2337/diabetes.48.4.801

  10. Homko, C J

    • Effect of insulin on fat metabolism during and after normal pregnancy. Diabetes April 1999 48:834-838; doi:10.2337/diabetes.48.4.834

  11. Horton, E S

    • Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats. Diabetes April 1999 48:801-812; doi:10.2337/diabetes.48.4.801

  12. Hounsom, L

    • Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes April 1999 48:881-889; doi:10.2337/diabetes.48.4.881

I

  1. Ihara, Y

    • Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes April 1999 48:927-932; doi:10.2337/diabetes.48.4.927

  2. Ikeda, H

    • Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes April 1999 48:927-932; doi:10.2337/diabetes.48.4.927

  3. Ipp, E

    • Glucose entrainment of high-frequency plasma insulin oscillations in control and type 2 diabetic subjects. Diabetes April 1999 48:714-721; doi:10.2337/diabetes.48.4.714

J

  1. Jiang, F X

    • Laminin-1 promotes differentiation of fetal mouse pancreatic beta-cells. Diabetes April 1999 48:722-730; doi:10.2337/diabetes.48.4.722

  2. Juhan-Vague, I

    • Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes April 1999 48:890-895; doi:10.2337/diabetes.48.4.890

K

  1. Kafri, T

    • Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes April 1999 48:745-753; doi:10.2337/diabetes.48.4.745

  2. Kaiser, N

    • Interaction between genetic and dietary factors determines beta-cell function in Psammomys obesus, an animal model of type 2 diabetes. Diabetes April 1999 48:731-737; doi:10.2337/diabetes.48.4.731
    • Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes April 1999 48:738-744; doi:10.2337/diabetes.48.4.738

  3. Kelley, D E

    • Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes April 1999 48:839-847; doi:10.2337/diabetes.48.4.839

  4. Kenny, D

    • Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes April 1999 48:870-880; doi:10.2337/diabetes.48.4.870

  5. Khan, B V

    • Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes April 1999 48:855-864; doi:10.2337/diabetes.48.4.855

  6. Kjos, S L

    • Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes April 1999 48:848-854; doi:10.2337/diabetes.48.4.848

L

  1. Lachin, J

    • Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes April 1999 48:870-880; doi:10.2337/diabetes.48.4.870

  2. Laville, M

    • Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes April 1999 48:699-705; doi:10.2337/diabetes.48.4.699

  3. Laviola, L

    • Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats. Diabetes April 1999 48:801-812; doi:10.2337/diabetes.48.4.801

  4. Lee, W P

    • Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes April 1999 48:848-854; doi:10.2337/diabetes.48.4.848

  5. Leibowitz, G

    • Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes April 1999 48:745-753; doi:10.2337/diabetes.48.4.745

  6. Levine, F

    • Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes April 1999 48:745-753; doi:10.2337/diabetes.48.4.745

  7. Lewis, G F

    • Free fatty acids impair hepatic insulin extraction in vivo. Diabetes April 1999 48:766-774; doi:10.2337/diabetes.48.4.766

  8. Lijnen, H R

    • Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes April 1999 48:890-895; doi:10.2337/diabetes.48.4.890

  9. Logoluso, F

    • Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats. Diabetes April 1999 48:801-812; doi:10.2337/diabetes.48.4.801

  10. Lopez, A D

    • Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes April 1999 48:745-753; doi:10.2337/diabetes.48.4.745

M

  1. Maassen, J A

    • Altered beta-cell characteristics in impaired glucose tolerant carriers of a GAA trinucleotide repeat polymorphism in the frataxin gene. Diabetes April 1999 48:924-926; doi:10.2337/diabetes.48.4.924

  2. Mao, C S

    • Glucose entrainment of high-frequency plasma insulin oscillations in control and type 2 diabetic subjects. Diabetes April 1999 48:714-721; doi:10.2337/diabetes.48.4.714

  3. Mari, A

    • Free fatty acids impair hepatic insulin extraction in vivo. Diabetes April 1999 48:766-774; doi:10.2337/diabetes.48.4.766

  4. Mauer, M

    • Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes April 1999 48:865-869; doi:10.2337/diabetes.48.4.865

  5. McCall, R H

    • Free fatty acids impair hepatic insulin extraction in vivo. Diabetes April 1999 48:766-774; doi:10.2337/diabetes.48.4.766

  6. Medford, R M

    • Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes April 1999 48:855-864; doi:10.2337/diabetes.48.4.855

  7. Meier, A

    • Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes April 1999 48:839-847; doi:10.2337/diabetes.48.4.839

  8. Miller, M E

    • Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes April 1999 48:865-869; doi:10.2337/diabetes.48.4.865

  9. Monnier, V M

    • Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes April 1999 48:870-880; doi:10.2337/diabetes.48.4.870

  10. Mooney, M H

    • NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity. Diabetes April 1999 48:758-765; doi:10.2337/diabetes.48.4.758

  11. Morange, P E

    • Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes April 1999 48:890-895; doi:10.2337/diabetes.48.4.890

  12. Mudaliar, S R

    • Inhibition of LDL oxidation in vitro but not ex vivo by troglitazone. Diabetes April 1999 48:783-790; doi:10.2337/diabetes.48.4.783

N

  1. Nanjo, K

    • Expression of naturally occurring variants in the muscle glycogen synthase gene. Diabetes April 1999 48:918-920; doi:10.2337/diabetes.48.4.918

  2. Napoli, R

    • Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats. Diabetes April 1999 48:801-812; doi:10.2337/diabetes.48.4.801

  3. Natarajan, R

    • Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes April 1999 48:855-864; doi:10.2337/diabetes.48.4.855

  4. Négrel, R

    • Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes April 1999 48:890-895; doi:10.2337/diabetes.48.4.890

  5. Nelson, R G

    • Effect of glycemia on mortality in Pima Indians with type 2 diabetes. Diabetes April 1999 48:896-902; doi:10.2337/diabetes.48.4.896

  6. Nesher, R

    • Interaction between genetic and dietary factors determines beta-cell function in Psammomys obesus, an animal model of type 2 diabetes. Diabetes April 1999 48:731-737; doi:10.2337/diabetes.48.4.731

O

  1. O'Harte, F P

    • NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity. Diabetes April 1999 48:758-765; doi:10.2337/diabetes.48.4.758

  2. Odaka, H

    • Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes April 1999 48:927-932; doi:10.2337/diabetes.48.4.927

  3. Onaya, T

    • DNA demethylation during the differentiation of 3T3-L1 cells affects the expression of the mouse GLUT4 gene. Diabetes April 1999 48:685-690; doi:10.2337/diabetes.48.4.685

  4. Orho-Melander, M

    • Expression of naturally occurring variants in the muscle glycogen synthase gene. Diabetes April 1999 48:918-920; doi:10.2337/diabetes.48.4.918

P

  1. Patel, J

    • Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes April 1999 48:881-889; doi:10.2337/diabetes.48.4.881

  2. Pedersen, O

    • Intermediate expansions of a GAA repeat in the frataxin gene are not associated with type 2 diabetes or altered glucose-induced beta-cell function in Danish Caucasians. Diabetes April 1999 48:914-917; doi:10.2337/diabetes.48.4.914
    • Expression of naturally occurring variants in the muscle glycogen synthase gene. Diabetes April 1999 48:918-920; doi:10.2337/diabetes.48.4.918

  3. Peiretti, F

    • Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes April 1999 48:890-895; doi:10.2337/diabetes.48.4.890

  4. Peters, R K

    • Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes April 1999 48:848-854; doi:10.2337/diabetes.48.4.848

  5. Polonsky, K

    • Free fatty acids impair hepatic insulin extraction in vivo. Diabetes April 1999 48:766-774; doi:10.2337/diabetes.48.4.766

  6. Priestley, J V

    • Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes April 1999 48:881-889; doi:10.2337/diabetes.48.4.881

R

  1. Rasmussen, S K

    • Expression of naturally occurring variants in the muscle glycogen synthase gene. Diabetes April 1999 48:918-920; doi:10.2337/diabetes.48.4.918

  2. Reece, E A

    • Effect of insulin on fat metabolism during and after normal pregnancy. Diabetes April 1999 48:834-838; doi:10.2337/diabetes.48.4.834

  3. Reeds, P J

    • Gluconeogenesis in very low birth weight infants receiving total parenteral nutrition. Diabetes April 1999 48:791-800; doi:10.2337/diabetes.48.4.791

  4. Rich, S S

    • Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes April 1999 48:865-869; doi:10.2337/diabetes.48.4.865

  5. Rieusset, J

    • Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes April 1999 48:699-705; doi:10.2337/diabetes.48.4.699

  6. Riou, J P

    • Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes April 1999 48:699-705; doi:10.2337/diabetes.48.4.699

  7. Roberts, K

    • Glucose entrainment of high-frequency plasma insulin oscillations in control and type 2 diabetic subjects. Diabetes April 1999 48:714-721; doi:10.2337/diabetes.48.4.714

  8. Roques, M

    • Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes April 1999 48:699-705; doi:10.2337/diabetes.48.4.699

  9. Rossetti, L

    • Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle. Diabetes April 1999 48:775-782; doi:10.2337/diabetes.48.4.775

  10. Ruige, J B

    • Altered beta-cell characteristics in impaired glucose tolerant carriers of a GAA trinucleotide repeat polymorphism in the frataxin gene. Diabetes April 1999 48:924-926; doi:10.2337/diabetes.48.4.924

S

  1. Sandhu, H

    • Free fatty acids impair hepatic insulin extraction in vivo. Diabetes April 1999 48:766-774; doi:10.2337/diabetes.48.4.766

  2. Sandler, S

    • Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes April 1999 48:706-713; doi:10.2337/diabetes.48.4.706

  3. Sanke, T

    • Expression of naturally occurring variants in the muscle glycogen synthase gene. Diabetes April 1999 48:918-920; doi:10.2337/diabetes.48.4.918

  4. Schanler, R J

    • Gluconeogenesis in very low birth weight infants receiving total parenteral nutrition. Diabetes April 1999 48:791-800; doi:10.2337/diabetes.48.4.791

  5. Schwartz, M W

    • Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes April 1999 48:828-833; doi:10.2337/diabetes.48.4.828

  6. Seino, Y

    • Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes April 1999 48:927-932; doi:10.2337/diabetes.48.4.927

  7. Sell, D R

    • Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes April 1999 48:870-880; doi:10.2337/diabetes.48.4.870

  8. Shimomura, H

    • Expression of naturally occurring variants in the muscle glycogen synthase gene. Diabetes April 1999 48:918-920; doi:10.2337/diabetes.48.4.918

  9. Shi, Z Q

    • Free fatty acids impair hepatic insulin extraction in vivo. Diabetes April 1999 48:766-774; doi:10.2337/diabetes.48.4.766

  10. Sievers, M L

    • Effect of glycemia on mortality in Pima Indians with type 2 diabetes. Diabetes April 1999 48:896-902; doi:10.2337/diabetes.48.4.896

  11. Sivan, E

    • Effect of insulin on fat metabolism during and after normal pregnancy. Diabetes April 1999 48:834-838; doi:10.2337/diabetes.48.4.834

  12. Smith, R J

    • Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats. Diabetes April 1999 48:801-812; doi:10.2337/diabetes.48.4.801

  13. Sorisky, A

    • Activation of protein kinase B and induction of adipogenesis by insulin in 3T3-L1 preadipocytes: contribution of phosphoinositide-3,4,5-trisphosphate versus phosphoinositide-3,4-bisphosphate. Diabetes April 1999 48:691-698; doi:10.2337/diabetes.48.4.691

  14. Steffes, M W

    • Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes April 1999 48:865-869; doi:10.2337/diabetes.48.4.865

  15. Stehouwer, C D

    • Altered beta-cell characteristics in impaired glucose tolerant carriers of a GAA trinucleotide repeat polymorphism in the frataxin gene. Diabetes April 1999 48:924-926; doi:10.2337/diabetes.48.4.924

  16. Stenbit, A E

    • Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle. Diabetes April 1999 48:775-782; doi:10.2337/diabetes.48.4.775

  17. Sunehag, A L

    • Gluconeogenesis in very low birth weight infants receiving total parenteral nutrition. Diabetes April 1999 48:791-800; doi:10.2337/diabetes.48.4.791

T

  1. Tack, C J

    • Allelic drop-out in exon 2 of the hepatocyte nuclear factor-1alpha gene hinders the identification of mutations in three families with maturity-onset diabetes of the young. Diabetes April 1999 48:921-923; doi:10.2337/diabetes.48.4.921

  2. Tanaka, T

    • Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes April 1999 48:927-932; doi:10.2337/diabetes.48.4.927

  3. Tawata, M

    • DNA demethylation during the differentiation of 3T3-L1 cells affects the expression of the mouse GLUT4 gene. Diabetes April 1999 48:685-690; doi:10.2337/diabetes.48.4.685

  4. Tchipashvili, V

    • Free fatty acids impair hepatic insulin extraction in vivo. Diabetes April 1999 48:766-774; doi:10.2337/diabetes.48.4.766

  5. Thaete, F L

    • Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes April 1999 48:839-847; doi:10.2337/diabetes.48.4.839

  6. t Hart, L M

    • Altered beta-cell characteristics in impaired glucose tolerant carriers of a GAA trinucleotide repeat polymorphism in the frataxin gene. Diabetes April 1999 48:924-926; doi:10.2337/diabetes.48.4.924

  7. Tomlinson, D R

    • Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes April 1999 48:881-889; doi:10.2337/diabetes.48.4.881

  8. Toyokuni, S

    • Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes April 1999 48:927-932; doi:10.2337/diabetes.48.4.927

  9. Trigo, E

    • Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes April 1999 48:848-854; doi:10.2337/diabetes.48.4.848

  10. Tsao, T S

    • Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle. Diabetes April 1999 48:775-782; doi:10.2337/diabetes.48.4.775

  11. Tyrberg, B

    • Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes April 1999 48:706-713; doi:10.2337/diabetes.48.4.706

U

  1. Uchida, K

    • Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes April 1999 48:927-932; doi:10.2337/diabetes.48.4.927

  2. Urhammer, S A

    • Intermediate expansions of a GAA repeat in the frataxin gene are not associated with type 2 diabetes or altered glucose-induced beta-cell function in Danish Caucasians. Diabetes April 1999 48:914-917; doi:10.2337/diabetes.48.4.914

V

  1. Vague, P

    • Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes April 1999 48:890-895; doi:10.2337/diabetes.48.4.890

  2. Valdeolmillos, M

    • Glucose-dependent stimulatory effect of glucagon-like peptide 1(7-36) amide on the electrical activity of pancreatic beta-cells recorded in vivo. Diabetes April 1999 48:754-757; doi:10.2337/diabetes.48.4.754

  3. Vallier, P

    • Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes April 1999 48:699-705; doi:10.2337/diabetes.48.4.699

  4. Vehkavaara, S

    • Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes April 1999 48:821-827; doi:10.2337/diabetes.48.4.821

  5. Verdier, M

    • Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes April 1999 48:890-895; doi:10.2337/diabetes.48.4.890

  6. Vidal, H

    • Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes April 1999 48:699-705; doi:10.2337/diabetes.48.4.699

W

  1. Weir, G C

    • Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats. Diabetes April 1999 48:801-812; doi:10.2337/diabetes.48.4.801

  2. Welsh, N

    • Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. Diabetes April 1999 48:813-820; doi:10.2337/diabetes.48.4.813

  3. Wentzel, P

    • Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. Diabetes April 1999 48:813-820; doi:10.2337/diabetes.48.4.813

  4. Westerbacka, J

    • Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes April 1999 48:821-827; doi:10.2337/diabetes.48.4.821

  5. Wiesenthal, S R

    • Free fatty acids impair hepatic insulin extraction in vivo. Diabetes April 1999 48:766-774; doi:10.2337/diabetes.48.4.766

  6. Wilkinson, I

    • Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes April 1999 48:821-827; doi:10.2337/diabetes.48.4.821

  7. Wing, R R

    • Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes April 1999 48:839-847; doi:10.2337/diabetes.48.4.839

X

  1. Xiang, A H

    • Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes April 1999 48:848-854; doi:10.2337/diabetes.48.4.848

Y

  1. Yamada, Y

    • Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes April 1999 48:927-932; doi:10.2337/diabetes.48.4.927

  2. Yerneni, K K

    • Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes April 1999 48:855-864; doi:10.2337/diabetes.48.4.855

  3. Yki-Järvinen, H

    • Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes April 1999 48:821-827; doi:10.2337/diabetes.48.4.821

  4. Yokomori, N

    • DNA demethylation during the differentiation of 3T3-L1 cells affects the expression of the mouse GLUT4 gene. Diabetes April 1999 48:685-690; doi:10.2337/diabetes.48.4.685

  5. Yoshii, H

    • Free fatty acids impair hepatic insulin extraction in vivo. Diabetes April 1999 48:766-774; doi:10.2337/diabetes.48.4.766

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement